An overwhelming number of comments submitted to the Drug Enforcement Administration (DEA) on the proposal to reschedule cannabis under the Controlled Substances Act favored the reforms or urged the government to deschedule cannabis entirely, according to an analysis by cannabis intelligence firm Headset. The analysis found 57% of comments submitted during the public comment period favored descheduling cannabis entirely, 35% supported rescheduling cannabis, and just 8% opposed the reforms, favoring keeping cannabis as a Schedule I drug.
According to the data, most comments were submitted on the very last day of the period. Of those, 5,093 favored either rescheduling or descheduling, with just 169 comments opposed. Not during a single day of the comment period were there more comments opposed to the reforms than in support. On July 15, there were 497 opposition comments submitted and 539 in support – marking the thinnest daily margin during the period.
“These numbers paint a clear picture: over 9 out of 10 individuals who took the time to comment believe that cannabis should not remain a Schedule I substance. Moreover, the majority of commenters went beyond the proposed rescheduling to Schedule III, arguing for complete removal from the